Abstract

The treatment of human immunodeficiency virus (HIV)-infected pregnant women is one of the most effective HIV-prevention interventions known. With prenatal testing, antiviral therapy, scheduled cesarean section when indicated, and formula feeding when feasible, rates of neonatal and perinatal HIV infection can diminish significantly. Although significant prevention is achievable, new cases of HIV in neonates continue to occur both worldwide and locally due to limited resources, delayed diagnosis, lack of linkage to care, and lack of timely effective therapy. Where those resources are available, the management of HIV infection in the pregnant woman requires a multidisciplinary expert approach to achieve optimal outcomes for both mother and child.

Links

Publisher Full Text

Authors

Davis JA, Yawetz S

Institution

Division of Infectious Diseases, The Ohio State University, Columbus, Ohio, USA. john.davis@osumc.edu

Source

Clinical obstetrics and gynecology 55:2 2012 Jun pg 531-40

MeSH

Anti-HIV Agents
Breast Feeding
CD4 Lymphocyte Count
Cesarean Section
Female
HIV Infections
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical
Labor, Obstetric
Postnatal Care
Preconception Care
Pregnancy
Pregnancy Complications, Infectious
Viral Load

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22510636